Icahn Capital Lowers Stake in Biogen Idec, Inc. (BIIB) to 3.4%

In a 13D filing on Biogen Idec, Inc. (NASDAQ: BIIB), Carl Icahn disclosed a 3.4%, or 8,225,256 share, stake in the company. This is down 38.75% from the 13,429,016 shares (5.56% stake) held at May 20, 2011.

For more notable holders of Biogen Idec, Inc. stock click here. For more information on Icahn Capital click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Biogen (BIIB) call put ratio 3.7 calls to 1 put with a focus on September calls
• Mavis acquires Pep Boys from Icahn Enterprises for $700M
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation